Trial Profile
A Randomized, Double-Blind, Multiple-Dose, Placebo-Controlled Tolerability And Pharmacokinetic Study Of Escalating Doses Of Albaconazole In Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Albaconazole (Primary)
- Indications Chagas disease; Onychomycosis; Tinea pedis; Vulvovaginal candidiasis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Stiefel Laboratories
- 10 Jun 2014 New trial record